(Q50079503)

English

Long-Term Efficacy and Safety of Interferon Alpha-2a in the Treatment of Chinese Patients with Behçet's Uveitis Not Responding to Conventional Therapy.

scientific article published on 17 October 2017

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/29040035

Long-Term Efficacy and Safety of Interferon Alpha-2a in the Treatment of Chinese Patients with Behçet's Uveitis Not Responding to Conventional Therapy. (English)

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/29040035

Behçet's disease

0 references

1 reference

based on heuristic

inferred from title

11

object named as

Aize Kijlstra

1 reference

Europe PubMed Central

24 February 2018

author name string

Peizeng Yang

1

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/29040035

Guo Huang

2

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/29040035

Liping Du

3

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/29040035

Zi Ye

4

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/29040035

Ke Hu

5

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/29040035

Chaokui Wang

6

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/29040035

Jian Qi

7

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/29040035

Liang Liang

8

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/29040035

Lili Wu

9

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/29040035

Qingfeng Cao

10

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/29040035

publication date

17 October 2017

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/29040035

Ocular Immunology and Inflammation

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/29040035

1-8

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/29040035

Behçet Uveitis.

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2017.1384026

21 January 2018

Behçet's disease: from Hippocrates to the third millennium

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2017.1384026

21 January 2018

Update on the therapy of Behçet disease

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2017.1384026

21 January 2018

Uveitis in Behçet disease: an analysis of 880 patients.

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2017.1384026

21 January 2018

Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2017.1384026

21 January 2018

Clinical features of chinese patients with Behçet's disease

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2017.1384026

21 January 2018

Therapy of ocular Behçet disease

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2017.1384026

21 January 2018

Safety and effectiveness of interferon alpha-2a in treatment of patients with Behçet's uveitis refractory to conventional treatments

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2017.1384026

21 January 2018

Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2017.1384026

21 January 2018

Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2017.1384026

21 January 2018

The use of interferon alpha in Behçet disease: review of the literature

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2017.1384026

21 January 2018

Efficacy of interferon alfa-2a in severe and refractory uveitis associated with Behçet's disease

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2017.1384026

21 January 2018

Long-term efficacy and safety of low-dose interferon alpha2a therapy in severe uveitis associated with Behçet disease

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2017.1384026

21 January 2018

Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2017.1384026

21 January 2018

Molecular Genetic Advances in Uveitis

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2017.1384026

21 January 2018

Current concepts in the etiology and treatment of Behçet disease

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2017.1384026

21 January 2018

Rescue of interferon induced bone marrow aplasia in a patient with chronic myeloid leukemia by allogeneic bone marrow transplant

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2017.1384026

21 January 2018

Clinical toxicity of interferons in cancer patients: a review

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2017.1384026

21 January 2018

Visual loss during interferon-alpha therapy in hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2017.1384026

21 January 2018

Posterior segment complications in patients with hepatitis C treated with interferon and ribavirin

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2017.1384026

21 January 2018

Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2017.1384026

21 January 2018

Efficacy of interferon-alpha for the treatment of Kaposi's sarcoma herpesvirus-associated uveitis.

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2017.1384026

21 January 2018

Familial recurrent bilateral panuveitis: efficiency of alpha interferon

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2017.1384026

21 January 2018

Interferon alpha-2a treatment for serpiginous choroiditis

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2017.1384026

21 January 2018

Immune response genes in uveitis

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2017.1384026

21 January 2018

Identifiers

10.1080/09273948.2017.1384026

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/29040035

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/29040035

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50079503&oldid=1185771525"